Prostate Cancer Clinical Trials in Brooklyn, New York

5 studies are recruiting for prostate cancer in Brooklyn, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

   Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, onco…

   Stage

   Not phased

   Ages

   40 to 95

   Site

   NYU Langone Health - Cobble Hill, Brooklyn, New York

   Locations

   2 in total

   Run by

   NYU Langone Health

   See if you can join NCT07203482 on ClinicalTrials.gov

2. Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

   Genetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Ge…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Kings County Hopsital Center, Brooklyn, New York

   Locations

   4 in total

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT04751435 on ClinicalTrials.gov

3. Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

   This is a phase I dose-escalation study of 225Ac-J591 administered together with 177Lu-PSMA small molecule. Both drugs are designed to deliver radiation to prostate cancer cells; they are known as radionuclide conjugates (radiation linked to antibodies/molecules that recognize prostate cancer cells…

   Stage

   Phase 1

   Ages

   18 to 99

   Site

   Brooklyn Methodist Hospital - New York Presbyterian, Brooklyn, New York

   Locations

   2 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04886986 on ClinicalTrials.gov

4. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

   Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cancer, including men with mHSPC and M0/M1 CRPC. The goal is to establish a population-based registry an…

   Stage

   Not phased

   Ages

   21 and older

   Site

   NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York

   Locations

   121 in total

   Run by

   Prostate Cancer Clinical Trials Consortium

   See if you can join NCT03151629 on ClinicalTrials.gov

5. Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

   This is a phase I/II study investigating the combination of 225Ac-J591 (a drug that can deliver radiation to prostate cancer cells) with pembrolizumab (immunotherapy, a drug that increases the immune system's ability to destroy cancer cells). This study will assess whether 225Ac-J591 + pembrolizuma…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   New York Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York

   Locations

   4 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04946370 on ClinicalTrials.gov